BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology Centre, Singapore.
Lab Chip. 2011 Jun 7;11(11):1870-8. doi: 10.1039/c0lc00633e. Epub 2011 Apr 19.
Blood is a highly complex bio-fluid with cellular components making up >40% of the total volume, thus making its analysis challenging and time-consuming. In this work, we introduce a high-throughput size-based separation method for processing diluted blood using inertial microfluidics. The technique takes advantage of the preferential cell focusing in high aspect-ratio microchannels coupled with pinched flow dynamics for isolating low abundance cells from blood. As an application of the developed technique, we demonstrate the isolation of cancer cells (circulating tumor cells (CTCs)) spiked in blood by exploiting the difference in size between CTCs and hematologic cells. The microchannel dimensions and processing parameters were optimized to enable high throughput and high resolution separation, comparable to existing CTC isolation technologies. Results from experiments conducted with MCF-7 cells spiked into whole blood indicate >80% cell recovery with an impressive 3.25 × 10(5) fold enrichment over red blood cells (RBCs) and 1.2 × 10(4) fold enrichment over peripheral blood leukocytes (PBL). In spite of a 20× sample dilution, the fast operating flow rate allows the processing of ∼10(8) cells min(-1) through a single microfluidic device. The device design can be easily customized for isolating other rare cells from blood including peripheral blood leukocytes and fetal nucleated red blood cells by simply varying the 'pinching' width. The advantage of simple label-free separation, combined with the ability to retrieve viable cells post enrichment and minimal sample pre-processing presents numerous applications for use in clinical diagnosis and conducting fundamental studies.
血液是一种高度复杂的生物流体,其中细胞成分占总体积的>40%,因此其分析具有挑战性且耗时。在这项工作中,我们介绍了一种基于高通量尺寸的分离方法,用于使用惯性微流控处理稀释血液。该技术利用高纵横比微通道中细胞的优先聚焦以及夹流动力学,从血液中分离出低丰度的细胞。作为所开发技术的应用,我们展示了通过利用循环肿瘤细胞(CTC)与血液细胞在大小上的差异,从血液中分离出 CTC。优化了微通道尺寸和处理参数,以实现高通量和高分辨率的分离,可与现有的 CTC 分离技术相媲美。用 MCF-7 细胞掺入全血进行的实验结果表明,细胞回收率>80%,与红细胞(RBC)相比富集了 3.25×10(5)倍,与外周血白细胞(PBL)相比富集了 1.2×10(4)倍。尽管样品稀释了 20 倍,但快速操作的流速允许通过单个微流控设备处理约 10(8)个细胞 min(-1)。该设备设计可以通过简单改变“夹断”宽度,轻松定制用于从血液中分离其他稀有细胞,包括外周血白细胞和胎儿有核红细胞。无需标记的简单分离的优势,结合富集后能够回收存活细胞和最小的样品预处理,为临床诊断和进行基础研究提供了众多应用。